Primary myelofibrosis and Swelling

Summary:

Swelling is found among people with Primary myelofibrosis, especially for people who are female, 60+ old.

The study analyzes which people have Swelling with Primary myelofibrosis. It is created by eHealthMe based on reports of 207 people who have Primary myelofibrosis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Primary myelofibrosis?

Primary myelofibrosis (primary disorder of the bone marrow) is found to be associated with 324 drugs and 840 conditions by eHealthMe. Check the latest studies of Primary myelofibrosis.

What is Swelling?

Swelling is found to be associated with 2,300 drugs and 2,892 conditions by eHealthMe. Check the latest studies of Swelling.

On Jul, 09, 2026

207 people who have Primary Myelofibrosis and Swelling are studied.

Would you have Swelling when you have Primary myelofibrosis?

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Swelling?

- Check whether Swelling is associated with a drug or a condition

Related studies:

Treatments, associated drugs and conditions:

Primary myelofibrosis (40,451 reports)
Swelling (115,742 reports)

All the drugs that are associated with Swelling:

Swelling (2,300 drugs)

All the conditions that are associated with Swelling:

Swelling (2,892 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Swelling and Primary myelofibrosis, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Primary myelofibrosis and Swelling

Summary:

What is Primary myelofibrosis?

What is Swelling?

Gender of people who have Primary myelofibrosis and experienced Swelling *:

Age of people who have Primary myelofibrosis and experienced Swelling *:

Common co-existing conditions for these people *:

Common drugs taken by these people *:

Common symptoms for these people *: